danazol has been researched along with Myeloproliferative Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gale, RP; Li, B; Pan, L; Qin, T; Qu, S; Wu, J; Xiao, Z; Xu, Z; Yan, X; Zhang, P; Zhang, Y | 1 |
| Bırce Sonmezoz, G; Dırıl, M; Gulturk, E; Yılmaz, D | 1 |
| Ahn, ER; Ahn, YS; Dudkiewicz, P; Fontana, V; Horstman, L | 1 |
| Ahn, YS; Brown, H; Horstman, LL; Kolodny, L; Sevin, BU | 1 |
| Fabris, F; Luzzatto, G; Randi, ML | 1 |
1 trial(s) available for danazol and Myeloproliferative Disorders
| Article | Year |
|---|---|
Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Danazol; Estrogen Antagonists; Female; Humans; Male; Middle Aged; Myeloproliferative Disorders; Pruritus | 1996 |
4 other study(ies) available for danazol and Myeloproliferative Disorders
| Article | Year |
|---|---|
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Topics: Anemia; Danazol; Hemoglobins; Humans; Myeloproliferative Disorders; Nitriles; Pilot Projects; Prednisone; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Thalidomide; Thrombocytopenia; Transaminases; Treatment Outcome | 2022 |
Temporal relationship between thromboembolic events and myeloproliferative neoplasm diagnosis: is it associated with mortality risk?
Topics: Aged; Aged, 80 and over; Danazol; Humans; Male; Middle Aged; Myeloproliferative Disorders; Neoplasms; Retrospective Studies; Thromboembolism | 2023 |
Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly with advanced MPD.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Danazol; Drug Administration Schedule; Estrogen Antagonists; Female; Humans; Male; Myeloproliferative Disorders; Remission Induction | 2011 |
Danazol in refractory pruritus of myeloproliferative disorders.
Topics: Danazol; Humans; Myeloproliferative Disorders; Pruritus | 1997 |